This is the old version of SRDR. The next, SRDRplus is available! Registration of your SRDRPlus account is free and approval is automatic. Click Here to register an SRDRPlus account.

Advanced Search

Study Preview



Study Title and Description

Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.



Key Questions Addressed
7 Key Question 7. What is the association between improvements in intermediate outcomes as a result of antiviral treatment of chronic HBV infection and reduction in risk of HBV-related adverse health outcomes?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.
Author Hui CK., Leung N., Shek WH., Zhang HY., Luk JM., Poon RT., Lo CM., Fan ST., Lau GK.
Country Department of Microbiology, The University of Hong Kong, Hong Kong SAR, China. ckhui23@gmail.com
Year -- Not Found --
Numbers Pubmed ID: 18344885

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-7


Results & Comparisons

No Results found.